Sato, Taku <br/><br/>
Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for polypoidal choroidal vasculopathy.  [electronic resource] 

 -  American journal of ophthalmology  Jun 2010 
 - 947-954.e1 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1879-1891 
<br/><br/><label>Standard No.: </label>10.1016/j.ajo.2009.12.038  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Angiogenesis Inhibitors--therapeutic use<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>Bevacizumab<br/>Choroid--blood supply<br/>Choroid Diseases--diagnosis<br/>Combined Modality Therapy<br/>Female<br/>Fluorescein Angiography<br/>Humans<br/>Injections<br/>Male<br/>Middle Aged<br/>Peripheral Vascular Diseases--diagnosis<br/>Photochemotherapy<br/>Photosensitizing Agents--therapeutic use<br/>Porphyrins--therapeutic use<br/>Retreatment<br/>Retrospective Studies<br/>Tomography, Optical Coherence<br/>Treatment Outcome<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors<br/>Verteporfin<br/>Visual Acuity--physiology<br/>Vitreous Body